• Organon hosts thought-provoking symposium titled “HERE for HER HEALTH”, in partnership with the Ministry of Health, Kuwait Diabetes Society, and the Kuwait Branch of the Arab Federation of Specialized Women.
• The event, which included prominent figures from the region's health and pharmaceutical industries, focused on the challenges women face and the significance of raising awareness about their health
Organon, the global healthcare company with a vision of a better and healthier every day for every woman, marked its launch in Kuwait with a groundbreaking scientific symposium attended by leading figures from the region's health and pharmaceutical sectors. The company's foray into the Kuwait market underscores a desire to expand its mission of delivering impactful medicines and solutions to as many people as possible in as many locations as possible.
Organon Kuwait team
The symposium titled HERE for HER HEALTH was organized in partnership with Ministry of Health, Kuwait Diabetes Society, and Arab Federation of Specialized Women Kuwait Branch and was addressed by Dr. Ghada Ibrahim, Director of Public Relations & Media Ministry of Health - Kuwait and Consultant Family Medicine - Ministry of Health Kuwait; Dr. Waleed Al Dhahi, Head of Kuwait Diabetes Society; Dr. Kalthoum Hussein, President of the Arab Federation of Specialized Women Kuwait Branch and Ahmed Lasheen, Kuwait, Qatar and Bahrain Organon Country Lead; Organon representatives and other leading industry players.
Commenting on the symposium and launch into Kuwait, Ahmed Lasheen said: “As a healthcare organization dedicated to improving the health of women, it was an honor to gather and host the key figures in the health sector to highlight various medical conditions that women may face. The symposium was unquestionably beneficial, providing expert medical insight and recommendations. We'll keep listening to women's needs to better understand the gaps and provide the appropriate solution so they can live better and healthier lives every day.
“We are entering Kuwait at a time of rapid, strong national growth, necessitating a focus on women's health issues and treatments that affect women daily. We aspire to influence change in the region by using our experience, treatments, and solutions in women's health to enable women to take control of their health and live better lives.”
Ahmed Lasheen, Kuwait, Qatar and Bahrain Organon Country Lead
Dr. Ghada Ibrahim, Director of Public Relations & Media Ministry of Health - Kuwait, spoke about the necessity of putting women's health first: "It is critical to prioritize women’s health. Many women are successful in their careers and may not set aside enough time to care for their health and well-being. They are the cornerstone of a family’s overall health and ensuring that they have access to high-quality care can improve the health of children and their families."
Dr. Ghada Ibrahim, Director of Public Relations & Media Ministry of Health - Kuwait and Consultant Family Medicine - Ministry of Health Kuwait
Dr. Kalthoum Hussein, President of the Arab Federation of Specialized Women Kuwait Branch, stressed on making collaborations to support women. He said: "Long-term partnerships based on mutual benefit are critical to empowering women and advancing gender equality in the workplace, economy, and community. Bringing together government, business, civil society, and grassroots leaders through a range of partnerships and multi-stakeholder engagements can aid in closing the gender gap."
Dr. Kalthoum Hussein, President of the Arab Federation of Specialized Women Kuwait Branch
Dr. Waleed Al Dhahi, Head of Kuwait Diabetes Society, said: “It was a privilege to participate in the HERE for HER HEALTH symposium. It's critical to bring together all stakeholders from various sectors of society to address women’s health, which is frequently overlooked by society, and educating them is critical. Adequate policies and strategies aimed at supporting women's health and well-being throughout their lives, are critical to helping women and girls reach their full potential.
Dr. Waleed Al Dhahi, Head of Kuwait Diabetes Society
Organon globally covers 140 markets with 60 drugs and solutions, with the goal of shifting the focus towards wider healthcare needs specifically in women health.
Organon's mission is to advance and innovate in the field of women's healthcare, in accordance with the United Nations Sustainable Development Goal of gender equality and female empowerment. The company’s debut in Kuwait will generate a better and healthier every day for every woman, as well as new employment possibilities and growing diversity in the healthcare profession, as the only global firm of its scale dedicated on women's health.
Organon's group picture
About Organon:
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.
Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.
For more information, visit www.organon.com and connect with us on LinkedIn, Instagram and Facebook.